Differentiating Asthma Severity Categories
Asthma severity is classified into four categories—intermittent, mild persistent, moderate persistent, and severe persistent—based on symptom frequency, nighttime awakenings, rescue inhaler use, lung function (FEV₁ and FEV₁/FVC ratio), and exacerbation frequency requiring oral corticosteroids. 1, 2, 1
Classification Framework
The classification system uses two domains: impairment (current symptoms and functional limitations) and risk (likelihood of exacerbations). Assign severity to the most severe category in which any feature occurs 1.
Specific Criteria for Each Category
Intermittent Asthma
- Symptoms: ≤2 days per week
- Nighttime awakenings: ≤2 times per month
- Rescue inhaler use: ≤2 days per week
- Activity limitation: None
- FEV₁: >80% predicted
- FEV₁/FVC ratio: Normal (85% for ages 8-19; 80% for ages 20-39; 75% for ages 40-59; 70% for ages 60-80)
- Exacerbations requiring oral steroids: 0-1 per year 1, 2, 3
Mild Persistent Asthma
- Symptoms: >2 days per week but not daily
- Nighttime awakenings: 3-4 times per month
- Rescue inhaler use: >2 days per week but not daily and not more than once per day
- Activity limitation: Minor limitation
- FEV₁: >80% predicted
- FEV₁/FVC ratio: Normal
- Exacerbations requiring oral steroids: 0-1 per year (though ≥2 per year may reclassify as persistent even with mild symptoms) 1, 3
Moderate Persistent Asthma
- Symptoms: Daily
- Nighttime awakenings: >1 time per week but not nightly
- Rescue inhaler use: Daily
- Activity limitation: Some limitation
- FEV₁: >60% but <80% predicted
- FEV₁/FVC ratio: Reduced by >5%
- Exacerbations requiring oral steroids: ≥2 per year 1, 2, 1
Severe Persistent Asthma
- Symptoms: Throughout the day
- Nighttime awakenings: Often 7 times per week (nightly)
- Rescue inhaler use: Several times per day
- Activity limitation: Extremely limited
- FEV₁: <60% predicted
- FEV₁/FVC ratio: Reduced
- Exacerbations requiring oral steroids: ≥2 per year 1
Critical Clinical Pearls
Important caveat: The term "mild intermittent" has been eliminated from current guidelines because patients at any severity level, including intermittent asthma, can experience severe exacerbations 1. This recognition is crucial—never dismiss intermittent asthma as trivial.
Exacerbation frequency trumps symptoms: Patients who experience ≥2 exacerbations requiring oral corticosteroids in the past year should be considered to have persistent asthma, even if their day-to-day symptoms suggest intermittent disease 1, 3, 1. This reflects the critical distinction between impairment and risk domains.
Assessment timeframe: Evaluate symptoms based on patient recall over the previous 2-4 weeks combined with spirometry 1.
Age-adjusted FEV₁/FVC ratios: Normal ratios decline with age—85% for ages 8-19,80% for ages 20-39,75% for ages 40-59, and 70% for ages 60-80 2, 3. Failure to adjust for age leads to misclassification.
Common Pitfalls to Avoid
Don't rely on symptoms alone. Many patients underestimate their symptom severity or accept limitations as normal 1. Always incorporate objective lung function testing.
Don't assume FEV₁ and peak flow are interchangeable. When expressed as percentage predicted, FEV₁ typically yields lower values than peak flow (mean difference of -17.2%), leading to different severity classifications in approximately 50% of cases 4.
Don't ignore controller medication use. Among patients classified as mild intermittent by symptoms alone, 22% are reclassified as persistent when controller medication use is considered 5.
Recognize that predictors of symptoms differ from predictors of exacerbations 6. A patient may have well-controlled daily symptoms but remain at high risk for severe exacerbations based on factors like younger age, prior hospitalizations, lower FEV₁/FVC ratio, and higher eosinophil counts.